Peer support program to improve cancer diagnosis and treatment for young people with HIV in Zambia
Integrated Delivery of Cancer Control Interventions for Adolescents and Young Adults Living With HIV in Zambia
This study is testing a peer support program to help young people with HIV in Zambia get diagnosed and treated for cancer more effectively.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 4100 (estimated) |
| Ages | 15 Years to 39 Years |
| Sex | All |
| Sponsor | Implenomics Academic / other |
| Locations | 1 site (Lusaka) |
| Trial ID | NCT06004011 on ClinicalTrials.gov |
What this trial studies
This study aims to address the high cancer mortality rates among adolescents and young adults living with HIV in Zambia by implementing a peer-to-peer education and support program. The ARROW program will focus on increasing the uptake of early cancer diagnosis services and improving compliance with cancer treatment for conditions such as cervical cancer, Kaposi sarcoma, and non-Hodgkin lymphoma. By embedding peer counselors and creating a learning network among healthcare providers, the study seeks to overcome barriers to cancer care in this vulnerable population. The effectiveness of these strategies will be evaluated using implementation science methods.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents and young adults aged 15 to 39 who have been on antiretroviral medication for at least six months.
Not a fit: Patients who are pregnant at the time of enrollment will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce cancer mortality rates among adolescents and young adults living with HIV in Zambia.
How similar studies have performed: Other studies have shown success with peer support strategies in improving health outcomes for similar populations, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 15 to 39 years of age at the time of study enrolment, on antiretroviral medication (ART) for at least 6 months and with no pending plans to move from current residence during the 3-year study duration Exclusion Criteria: * pregnant at study enrolment
Where this trial is running
Lusaka
- Public Health Facilities — Lusaka, Zambia (Recruiting)
Study contacts
- Study coordinator: Sujha Subramanian
- Email: sujha.subramanian@implenomics.com
- Phone: 3022225034
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.